Advances in the Treatment of Scleroderma: Autologous Hematopoietic Stem Cell Transplant

This accredited CME publication features a review of and expert commentary on the role of hematopoietic stem cell transplant (HSCT) in the treatment of diffuse systemic sclerosis (SSc). Clinical pearls from recent evidence are provided, as well as expert insight related to the novel, critical endpoint recently published from a landmark prospective clinical trial.

Online Publication
0.25 AMA PRA Category 1 Credit™

Ankoor Shah, MD
Assistant Professor, Division of Rheumatology and Immunology